FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
BioLineRx Announces Collaboration with MSD to Investigate the Combination of KEYTRUDA (pembrolizumab) and BL-8040 in Pancreatic Cancer
January 12, 2016
BioLineRx Announces Regulatory Submission for Phase 2 Trial of BL-8040 as Novel Stem Cell Mobilization Treatment
December 14, 2015
BioLineRx Establishes Oncology Scientific Advisory Board
December 03, 2015
Updates on Biotechnology Industry Stocks - BioCryst Pharma, Incyte, bluebird bio, Cempra, and BioLineRx
September 11, 2015
BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment
January 25, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here